シカゴでのCAR-T細胞療法—3つのパーソナライズクリニックマッチングを取得

Professor Omur Gokmen Sevindik, who completed a hematology fellowship at the Mayo Clinic, leads this treatment. The package costs approximately $200,000 – covering the entire 28-day inpatient cycle, all meals, and accommodation for one companion at the JCI-accredited Istanbul Florence Nightingale Hospital. This TÜV Hessen-certified smart hospital provides dedicated nursing and multi-language support. Patients should plan to stay in Istanbul for at least two months following discharge for monitoring.

This package provides personalized CAR-T cell dosing tailored to a patient's specific disease progression. Professor Ceyhun Bozkurt, a published SIOP/EBMT member with expertise in childhood blood disorders, leads the full-cycle management at Medical Park Bahcelievler Hospital. The approximate $300,000 fee covers a 28-day hospital stay in infection-controlled rooms with 24/7 monitoring. CAR-T cells are produced at the GMP-certified Acıbadem Labcell laboratory for safety. A bridge therapy option allows for continuous medical supervision prior to infusion if needed.